Johnson & Johnson (JNJ) Competitors $191.79 +0.62 (+0.32%) Closing price 03:59 PM EasternExtended Trading$192.18 +0.39 (+0.20%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOMShould you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM). Johnson & Johnson vs. Its Competitors Intuitive Surgical Moderna Novavax AbbVie Berkshire Hathaway Eli Lilly and Company Merck & Co., Inc. Pfizer Procter & Gamble Exxon Mobil Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Which has more risk and volatility, ISRG or JNJ? Intuitive Surgical has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Does the media favor ISRG or JNJ? In the previous week, Johnson & Johnson had 103 more articles in the media than Intuitive Surgical. MarketBeat recorded 177 mentions for Johnson & Johnson and 74 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.07 beat Johnson & Johnson's score of 1.00 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 53 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Johnson & Johnson 107 Very Positive mention(s) 17 Positive mention(s) 30 Neutral mention(s) 5 Negative mention(s) 8 Very Negative mention(s) Positive Which has stronger earnings & valuation, ISRG or JNJ? Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntuitive Surgical$9.15B17.04$2.32B$7.1760.62Johnson & Johnson$88.82B5.20$14.07B$9.3520.51 Do analysts rate ISRG or JNJ? Intuitive Surgical presently has a consensus target price of $580.29, suggesting a potential upside of 33.52%. Johnson & Johnson has a consensus target price of $199.59, suggesting a potential upside of 4.07%. Given Intuitive Surgical's higher possible upside, equities analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intuitive Surgical 1 Sell rating(s) 8 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.57Johnson & Johnson 0 Sell rating(s) 8 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.73 Do insiders & institutionals hold more shares of ISRG or JNJ? 83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is ISRG or JNJ more profitable? Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 27.26%. Johnson & Johnson's return on equity of 33.08% beat Intuitive Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Intuitive Surgical28.51% 14.56% 12.93% Johnson & Johnson 27.26%33.08%13.30% SummaryIntuitive Surgical beats Johnson & Johnson on 9 of the 17 factors compared between the two stocks. Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JNJ vs. The Competition Export to ExcelMetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE ExchangeMarket Cap$461.90B$268.09B$6.13B$21.70BDividend Yield2.72%2.61%5.73%3.62%P/E Ratio18.5130.7985.1529.79Price / Sales5.204.66574.6194.32Price / Cash14.5514.3637.3924.26Price / Book6.4619.5812.394.62Net Income$14.07B$8.49B$3.32B$1.01B7 Day Performance0.43%-2.02%-0.24%-0.79%1 Month Performance8.68%2.96%9.56%0.25%1 Year Performance16.75%-5.24%71.67%11.51% Johnson & Johnson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JNJJohnson & Johnson4.8507 of 5 stars$191.79+0.3%$199.59+4.1%+16.3%$461.90B$88.82B18.51138,100Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionISRGIntuitive Surgical4.9209 of 5 stars$436.79+1.7%$584.76+33.9%-9.0%$157.01B$9.15B61.0915,638Trending NewsUpcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionMRNAModerna4.2364 of 5 stars$26.95+0.4%$41.81+55.2%-51.6%$10.54B$3.06B-3.585,800NVAXNovavax3.9855 of 5 stars$8.68+4.1%$12.33+42.2%-29.3%$1.42B$682.16M3.831,990ABBVAbbVie4.6969 of 5 stars$231.77+0.6%$231.90+0.1%+18.0%$409.74B$56.33B110.4555,000Trending NewsAnalyst ForecastOptions VolumeAnalyst RevisionBRK.BBerkshire Hathaway2.1148 of 5 stars$492.13+0.6%$575.00+16.8%+7.2%$1.06T$371.43B16.89392,400LLYEli Lilly and Company4.9812 of 5 stars$822.39-1.3%$948.06+15.3%-9.6%$778.93B$45.04B53.7947,000Trending NewsAnalyst UpgradeAnalyst RevisionMRKMerck & Co., Inc.4.9993 of 5 stars$85.59-0.5%$105.00+22.7%-24.6%$213.92B$63.62B13.2075,000Trending NewsAnalyst ForecastAnalyst RevisionPFEPfizer4.9605 of 5 stars$24.81+0.1%$28.35+14.3%-17.2%$141.14B$63.63B13.2081,000Positive NewsDividend AnnouncementAnalyst RevisionPGProcter & Gamble4.7093 of 5 stars$147.33-1.6%$172.21+16.9%-15.1%$345.12B$84.28B22.65109,000Positive NewsDividend AnnouncementXOMExxon Mobil4.9343 of 5 stars$111.99+1.1%$126.05+12.6%-7.2%$477.77B$329.39B15.9261,000Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Intuitive Surgical Competitors Moderna Competitors Novavax Competitors AbbVie Competitors Berkshire Hathaway Competitors Eli Lilly and Company Competitors Merck & Co., Inc. Competitors Pfizer Competitors Procter & Gamble Competitors Exxon Mobil Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JNJ) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
